Cargando…
Therapeutic Potential of a Novel α(v)β(3) Antagonist to Hamper the Aggressiveness of Mesenchymal Triple Negative Breast Cancer Sub-Type
The mesenchymal sub-type of triple negative breast cancer (MES-TNBC) has a highly aggressive behavior and worse prognosis, due to its invasive and stem-like features, that correlate with metastatic dissemination and resistance to therapies. Furthermore, MES-TNBC is characterized by the expression of...
Autores principales: | Hill, Billy Samuel, Sarnella, Annachiara, Capasso, Domenica, Comegna, Daniela, Del Gatto, Annarita, Gramanzini, Matteo, Albanese, Sandra, Saviano, Michele, Zaccaro, Laura, Zannetti, Antonella |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6406933/ https://www.ncbi.nlm.nih.gov/pubmed/30682838 http://dx.doi.org/10.3390/cancers11020139 |
Ejemplares similares
-
Inhibition of carbonic anhydrases IX/XII by SLC-0111 boosts cisplatin effects in hampering head and neck squamous carcinoma cell growth and invasion
por: Sarnella, Annachiara, et al.
Publicado: (2022) -
Selective Targeting of αvβ5 Integrin in HepG2 Cell Line by RGDechi15D Peptide
por: Capasso, Domenica, et al.
Publicado: (2020) -
Inhibition of Bone Marrow-Mesenchymal Stem Cell-Induced Carbonic Anhydrase IX Potentiates Chemotherapy Efficacy in Triple-Negative Breast Cancer Cells
por: Sarnella, Annachiara, et al.
Publicado: (2023) -
Recent Advances in Nuclear Imaging of Receptor Expression to Guide Targeted Therapies in Breast Cancer
por: Salvatore, Barbara, et al.
Publicado: (2019) -
Inhibition of Bone Marrow-Derived Mesenchymal Stem Cells Homing Towards Triple-Negative Breast Cancer Microenvironment Using an Anti-PDGFRβ Aptamer
por: Camorani, Simona, et al.
Publicado: (2017)